Princeton, NJ – January 24, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division has acquired the Velos eResearch business line. Velos is a leading provider of clinical trial management solutions (CTMS) that increase the productivity and efficiency of clinical research. Velos links the administrative, financial, and regulatory elements of clinical research on a single, adaptable, easy-to-use technology platform making the execution of research more organized, more manageable and more profitable for institutions.
“We are pleased to welcome Velos to the WCG family,” said Donald A. Deieso, PhD, Executive Chairman and CEO of WCG. “WCG is privileged to serve more than 2,800 institutions, and we are thrilled to empower them with technology solutions that will increase the efficiency of their research programs.”
WCG partners with 93% of the institutions – and 90% of the academic medical centers – that conduct research in the United States. WCG helps institutions accommodate the changes which are occurring in the rapidly evolving drug development landscape by providing solutions that increase the efficiency and profitability of their research, accelerate patient enrollment and position them to attract increased industry funding.
“Our clients are recognized for their academic and clinical research excellence and scientific achievement,” said John S. McIlwain, MBA, Co-founder and CEO of Velos. “They are a critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”
An Internet platform solution, Velos eResearch simplifies the management of institutional research by linking study status, patient enrollment, calendars, budgets, billing, and electronic data capture (EDC). By centralizing the management of research activities – and the collection of research-related information – on a single electronic platform, Velos increases the efficiency, transparency and accessibility of institutional research.
Like WCG’s previous acquisitions, Velos will operate independently and retain its headquarters in Fremont, CA. WCG will support Velos with access to capital, expertise and corporate operational support.
About WCG (WIRB-Copernicus Group)
WCG is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. The industry’s first clinical services organization (CSO), WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protection. For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical or LinkedIn.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.